Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Stall, Bronwyn ^a   Zach, Leor ^a   Ning, Holly ^a   Ondos, John ^a   Arora, Barbara ^a   Shankavaram, Uma ^a   Miller, Robert W ^a   Citrin, Deborah ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE; VALPROIC ACID;

ADULT; AGED; ARTICLE; BRAIN EDEMA; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; GLIOMA; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; TOXICITY; TREATMENT PLANNING; TUMOR VOLUME; BRAIN TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 77249141155     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-5     Document Type: Article

References (34)

1. CBTRUS (2008) Statistical Report: Primary Brain Tumors in the United States, 2000-2004. Central Brain Tumor Registry of the United States 2008, CBTRUS (2008).
2. Garden AS, Maor MH, Yung WK. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 1991, 20:99-110. 10.1016/0167-8140(91)90143-5, 1851573.
3. Halperin EC, Bentel G, Heinz ER. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989, 17:1347-1350.
4. Kelly PJ, Daumas-Duport C, Kispert DB. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987, 66:865-874. 10.3171/jns.1987.66.6.0865, 3033172.
5. Wallner KE, Galicich JH, Krol G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989, 16:1405-1409.
6. Curran WJ, Scott CB, Horton J. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993, 85:704-710. 10.1093/jnci/85.9.704, 8478956.
7. Mirimanoff RO, Gorlia T, Mason W. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 2006, 24:2563-2569. 10.1200/JCO.2005.04.5963, 16735709.
8. Ten Haken RK, Thornton AF, Sandler HM. A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors. Radiother Oncol 1992, 25:121-133. 10.1016/0167-8140(92)90018-P, 1332134.
9. Thornton AF, Sandler HM, Ten Haken RK. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys 1992, 24:767-775.
10. Emami B, Lyman J, Brown A. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
11. Chan JL, Lee SW, Fraass BA. Survival and failure patterns of high-grade Gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002, 20:1635-1642. 10.1200/JCO.20.6.1635, 11896114.
12. Stupp R, Mason WP, Bent MJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009.
13. Kamrava M. Acute Toxicity in a Phase II Clinical Trial of Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with Glioblastoma Multiforme. Int J Radiat Oncol Biol Phys 2008, 72(Suppl 1):211.
14. Massey V, Wallner KE. Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 1990, 18:395-398.
15. Rontgen WC. On a New Kind of Rays. Science 1896, 3:227-231. 10.1126/science.3.59.227, 17769966.
16. Leeds NE, Kieffer SA. Evolution of diagnostic neuroradiology from 1904 to 1999. Radiology 2000, 217:309-318.
17. Aristizibal SA, Caldwell WL. Time-dose-volume relationships in the treatment of glioblastoma multiforme. Radiology 1971, 101:201-202.
18. Concannon JP, Kramer S, Berry R. The extent of intracranial gliomata at autopsy and its relationship to techniques used in radiation therapy of brain tumors. Am J Roentgenol Radium Ther Nucl Med 1960, 84:99-107.
19. Kilgore EJ, Elster AD. Walter Dandy and the history of ventriculography. Radiology 1995, 194:657-660.
20. Kramer S. Radiation therapy in the management of malignant gliomas. Proc Natl Cancer Conf 1972, 7:823-826.
21. Salazar OM, Rubin P. The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1976, 1:627-637.
22. Todd DH. Choice of Volume in the X-Ray Treatment of Supratentorial Gliomas. Br J Radiol 1963, 36:645-649. 10.1259/0007-1285-36-429-645, 14066157.
23. Hess CF, Schaaf JC, Kortmann RD. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994, 30:146-149. 10.1016/0167-8140(94)90044-2, 8184112.
24. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980, 30:907-911.
25. Salazar OM, Rubin P, McDonald JV. Patterns of failure in intracranial astrocytomas after irradiation: analysis of dose and field factors. AJR Am J Roentgenol 1976, 126:279-292.
26. Shapiro WR, Green SB, Burger PC. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989, 71:1-9. 10.3171/jns.1989.71.1.0001, 2661738.
27. Sharma RR, Singh DP, Pathak A. Local control of high-grade gliomas with limited volume irradiation versus whole brain irradiation. Neurol India 2003, 51:512-517.
28. Walker MD, Alexander E, Hunt WE. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978, 49:333-343. 10.3171/jns.1978.49.3.0333, 355604.
29. De Coene B, Hajnal JV, Gatehouse P. MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. AJNR Am J Neuroradiol 1992, 13:1555-1564.
30. Bydder GM, Young IR. MR imaging: clinical use of the inversion recovery sequence. J Comput Assist Tomogr 1985, 9:659-675.
31. Radiation Therapy Oncology Group Active Brain Protocols. Radiation Therapy Oncology Group ., http://rtog.org/members/active.html#brain
32. Grosu AL, Weber W, Feldman HJ. First experience with I-123-alpha-methyl tyrosine spect in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys 2000, 47:517-526. 10.1016/S0360-3016(00)00423-5, 10802381.
33. Mosskin M, Erickson K, Hindmarsh T. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989, 30:225-232. 10.3109/02841858909174670, 2660886.
34. Pirzkall A, McKnight TR, Graves EE. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 2001, 50:915-928. 10.1016/S0360-3016(01)01548-6, 11429219.